2018 was a strong year for our Tiara and Reducer product platforms. Both have achieved significant therapy development milestones, putting Neovasc on a stronger foundation from which to continue advancing these products commercially. We also have a clear value creation strategy for patients, employees, and investors. All of this is really good news for our outlook.
Investor Overview
Latest News
Neovasc will Request Nasdaq Hearing after Company Received Expected Delisting Determination from Nasdaq Staff
> read full release
Programs and Events
Neovasc Presentation - January 2020
Live Webcast - Neovasc Presentation at the
SVB Leerink Global Healthcare Conference
Wed. February 26th, 3:00p.m. EST
Neovasc CEO Fred Colen will be the presenter.
A replay will be accessible after the live webcast.
Financial Report Archives
2019 Financial Reports
News Release Archives
2020 News Releases
- Q1
- Q2
- Q3
- Q4
Share Information
Auditor
Grant Thornton LLP, Vancouver, BC
Legal Counsel
Blakes LLP, Vancouver, BC
Transfer Agent
Computershare, Vancouver, BC
Investor Relations
Chris Clark, Chief Financial Officer
investors@neovasc.com
To automatically receive news updates